Viewing Study NCT01582334


Ignite Creation Date: 2025-12-25 @ 2:35 AM
Ignite Modification Date: 2025-12-26 @ 1:11 AM
Study NCT ID: NCT01582334
Status: COMPLETED
Last Update Posted: 2017-12-26
First Post: 2012-04-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Argentina
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module